Pakistan Business News API

{
    "totalArticles": 371340,
    "articles": [
        {
            "id": "656c0c70cf62fb6f82a0f3a3f3fb5e77",
            "title": "Greenshoe option: Pakistan ups Eurobond issuance to $750m",
            "description": "ISLAMABAD: Pakistan has jacked up issuance of Eurobond to $750 million with an additional $250 million placed with global institutional investors through the exercise of the greenshoe...",
            "content": "ISLAMABAD: Pakistan has jacked up issuance of Eurobond to $750 million with an additional $250 million placed with global institutional investors through the exercise of the greenshoe option.\nAccording to an X post by Advisor to Finance Ministry Khur... [1455 chars]",
            "url": "https://www.thenews.pk/print/1411314-greenshoe-option-pakistan-ups-eurobond-issuance-to-750m",
            "image": "https://www.thenews.pk/assets/uploads/akhbar/2026-04-21/1411314_044332_updates.jpg",
            "publishedAt": "2026-04-21T00:05:57Z",
            "lang": "en",
            "source": {
                "id": "15f8b49064719ce40c43cd5c574f0bd4",
                "name": "The News Pakistan",
                "url": "https://www.thenews.pk"
            }
        },
        {
            "id": "1670a8c84b621c69226e1344d1a2b705",
            "title": "Amazon invest up to $25 billion in Anthropic part of AI infrastructure",
            "description": "Amazon is boosting its investment in Anthropic, which is committing to spending over $100 billion on Amazon cloud services over the next decade.",
            "content": "Amazon has agreed to invest up to $25 billion in Anthropic, on top of the $8 billion that it's poured into the artificial intelligence startup in recent years, as part of an expanded agreement to build out AI infrastructure.\nIn the announcement on Mo... [3153 chars]",
            "url": "https://www.cnbc.com/2026/04/20/amazon-invest-up-to-25-billion-in-anthropic-part-of-ai-infrastructure.html",
            "image": "https://image.cnbcfm.com/api/v1/image/108254538-1770326418274-108254538-1768938695162-CNBC_Stage_01_062.jpg?v=1771351348&w=1920&h=1080",
            "publishedAt": "2026-04-20T20:30:09Z",
            "lang": "en",
            "source": {
                "id": "32c2ad3fb41cb87b5b847d750028dff0",
                "name": "CNBC",
                "url": "https://www.cnbc.com"
            }
        },
        {
            "id": "227374701dbb6d2aebd342120ea09a9d",
            "title": "How Did Daraxonrasib Double Survival in Pretreated Metastatic Pancreatic Cancer?",
            "description": "Diane Simeone, MD, discussed efficacy results from the phase 3 RASolute 302 trial evaluating daraxonrasib in patients with metastatic pancreatic cancer.",
            "content": "The treatment landscape for pancreatic cancer has long been characterized by limited therapeutic options and a survival rate that has proven difficult to improve. However, data from the phase 3 RASolute 302 trial (NCT06284538), evaluating daraxonrasi... [11559 chars]",
            "url": "https://www.cancernetwork.com/view/how-did-daraxonrasib-double-survival-in-pretreated-metastatic-pancreatic-cancer-",
            "image": "https://cdn.sanity.io/images/0vv8moc6/cancernetwork/6bb0264161e930c46496abf34acaa4e69378db13-360x400.png",
            "publishedAt": "2026-04-20T20:04:16Z",
            "lang": "en",
            "source": {
                "id": "5aa24e4b1a0873860bbc7102ec053fb0",
                "name": "CancerNetwork",
                "url": "https://www.cancernetwork.com"
            }
        }
    ]
}